Aaron Pelta, MBA is Senior Vice President of Corporate Business Development at Morphic, where he is responsible for external partnering, portfolio strategy, and commercial planning. Most recently Aaron served as VP Business Development at Arsanis, a clinical stage infectious disease company, where he was a key member of the executive leadership team that completed a private financing round, IPO, and reverse merger. Prior to this role, Aaron severed in various senior leadership roles at Shire, AMAG and Cubist Pharmaceuticals. Over his twenty-year career, Aaron has led the execution of multiple buy and sell side BD transactions, including public-public M&A, covering research to commercial stage assets. His commercial experience spans commercial forecasting and analytics through in-line brand management. Aaron received his BS in Chemical Engineering from Tufts University and MBA from the Tuck School of Business at Dartmouth College.
Aaron Pelta, MBA
Senior Vice President, Corporate Business Development